
GenOway
A global biotechnology company dedicated to the development and commercialization of unique, innovative genetically modified mouse, rat and cell line models for fundamental, preclinical and clinical research.
Date | Investors | Amount | Round |
---|---|---|---|
N/A | €0.0 | round | |
investor | €0.0 | round | |
N/A | €5.6m | Private Placement VC | |
Total Funding | 000k |
EUR | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% growth | - | (5 %) | 16 % | 27 % | 22 % | 18 % | 10 % |
EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% EBITDA margin | 10 % | 4 % | 9 % | 11 % | 19 % | 30 % | 23 % |
Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% profit margin | - | (11 %) | (6 %) | (2 %) | 5 % | 8 % | 8 % |
EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
R&D % of revenue | 80 % | 106 % | 64 % | - | - | - | - |
Source: Company filings or news article
Related Content
Genoway specializes in the development of genetically modified mouse and rat models, serving the scientific research community. Operating in the biotechnology sector, the company collaborates closely with research institutions and pharmaceutical companies to provide customized transgenic animal models. Genoway's business model revolves around offering tailored solutions that meet specific research needs, utilizing both classical and innovative transgenesis technologies. Revenue is generated through project-based collaborations, where clients benefit from Genoway's expertise in creating models that accurately mimic human physiological responses. The company is recognized for its flexibility, allowing for bespoke project designs and frequent client communication. Key clients include universities and research organizations seeking reliable and precise animal models for their studies.
Keywords: transgenic, biotechnology, mouse models, rat models, scientific research, customized solutions, transgenesis, physiological relevancy, project-based, collaboration.
Tech stack
Investments by GenOway
Edit